# Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria

> **NCT02814630** · NA · COMPLETED · sponsor: **Asthma Inc Clinical Research Center** · enrollment: 20 (actual)

## Conditions studied

- Chronic Idiopathic Urticaria

## Interventions

- **BIOLOGICAL:** Xolair

## Key facts

- **NCT ID:** NCT02814630
- **Lead sponsor:** Asthma Inc Clinical Research Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-11-02
- **Final completion:** 2018-11-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02814630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02814630, "Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic Urticaria". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02814630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*